First-line regimen by period of initiation (n = 4662).
- David Charles Boettiger (625230)
- Stephen Kerr (625231)
- Rossana Ditangco (361612)
- Tuti Parwati Merati (625232)
- Thuy Thi Thanh Pham (625233)
- Romanee Chaiwarith (427726)
- Sasisopin Kiertiburanakul (427725)
- Chung Ki Patrick Li (625234)
- Nagalingeswaran Kumarasamy (36007)
- Saphonn Vonthanak (625235)
- Christopher Lee (11627)
- Nguyen Van Kinh (129736)
- Sanjay Pujari (428216)
- Wing Wai Wong (625236)
- Adeeba Kamarulzaman (307011)
- Fujie Zhang (155391)
- Evy Yunihastuti (428215)
- Jun Yong Choi (290863)
- Shinichi Oka (205454)
- Oon Tek Ng (134833)
- Pacharee Kantipong (311441)
- Mahiran Mustafa (625237)
- Winai Ratanasuwan (427729)
- Annette Sohn (625238)
- Matthew Law (36008)
Publication date
September 2014
DOIAbstract
<p>A <i>(d4T/AZT/TDF)/NNRTI</i> regimen comprises d4T/AZT/TDF + another NRTI + NNRTI. A <i>PI-based</i> regimen comprises dual NRTI + PI. <i>Other</i> regimen refers to all other ART. d4T = stavudine; AZT = zidovudine; TDF = tenofovir; NNRTI = non-nucleoside reverse transcriptase inhibitor; NRTI = nucleoside reverse transcriptase inhibitor; PI = protease inhibitor.</p
Add to ORKG